Risk factors

Ovid Therapeutics (OVID) risk factors

Item 1A of every Ovid Therapeutics Inc. 10-K on file, and what changed from one year to the next.

Open OVID in Gloomberb →
  • FY2025 10-K risk factors

    57 risks, 5 new, 14 dropped, 13 reworded since the prior year. Ovid Therapeutics updated its financial figures showing cash of $90.4 million and an accumulated deficit of $321.7 million. New risk factors highlight macroeconomic uncertainties, potential FDA disruptions from government shutdowns, and patient population estimation challenges for brain disorders.

    Filed Mar 18, 2026
  • FY2024 10-K risk factors

    66 risks. Ovid Therapeutics faces significant cash burn, holding $53.1 million against an accumulated deficit of $304.3 million.

    Filed Mar 11, 2025